CRISPR: Clustered Regularly Interspaced Short Palindromic Repeats.
Discovered in 1987 by Yoshizumi Ishino and later developed as a genome-editing tool by Emmanuelle Charpentier and Jennifer Doudna.
CRISPR was discovered in the bacteria Escherichia coli.
CRISPR evolved as a bacterial immune system to protect against viral infections by recognizing and cutting the DNA of invading phages.
Gene editing: Modifying or correcting genetic sequences in organisms.
Gene regulation: Turning genes on or off by modifying promoters or other regulatory regions.
Guide RNAs (gRNAs) are synthetic or natural RNA molecules that direct the Cas9 enzyme to a specific DNA sequence for cutting.
Cas (CRISPR-associated) proteins, such as Cas9, act as molecular scissors, cutting DNA at precise locations specified by the guide RNA.
CRISPR allows for precise, efficient, and cost-effective editing of specific DNA sequences, enabling breakthroughs in genetic research, medicine, and agriculture.
Use in human germline editing, potentially altering future generations.
Concerns about designer babies.
Risks of unintended genetic consequences or ecological impacts.
Unequal access to CRISPR technology.
Knockout mutations: Disabling specific genes to study their function.
Gene correction: Repairing faulty genes to treat genetic disorders.
Sickle cell anemia.
Beta-thalassemia.
Leber’s congenital amaurosis (a genetic eye disorder).
Certain cancers.
Huntington's disease.
Winners: Emmanuelle Charpentier and Jennifer Doudna won the Nobel Prize in Chemistry in 2020 for developing CRISPR-Cas9 as a genome-editing tool.
Plasmid: A circular, double-stranded DNA molecule independent of chromosomal DNA in bacteria.
Common genes: Antibiotic resistance, metabolic enzymes, or virulence factors.
Plasmids often carry antibiotic resistance genes and can transfer them between bacteria via horizontal gene transfer.
Conjugation: Transfer through direct cell-to-cell contact.
Transformation: Uptake from the environment.
Transduction: Transfer by bacteriophages.
Efflux pumps: Remove antibiotics from the cell.
Enzymatic degradation: Break down antibiotics (e.g., β-lactamases).
Target modification: Alter the antibiotic’s binding site.
Reduced permeability: Limit antibiotic entry into the cell.
Lawn of cells: Uniform bacterial growth on a petri dish.
Phages: Viruses that infect bacteria.
Plaque: Clear zones on a bacterial lawn where phages have lysed cells.
Specificity: Target specific bacteria without harming others.
Resistance: Can evolve to counteract bacterial resistance.
Low side effects: Less likely to disrupt the microbiome.
CRISPR’s guide RNA is similar to:
Telomerase RNA: Guides telomerase to the ends of chromosomes.
Ribosomal RNA: Positions the ribosome on mRNA for protein synthesis.
Fluorescent In Situ Hybridization (FISH) probes are labeled DNA or RNA sequences that bind to specific genomic regions. Detection is via fluorescence microscopy.
Interphase nuclei: Chromatin is less condensed, showing dispersed signals.
Prophase-metaphase nuclei: Chromosomes are highly condensed, showing discrete signals.
Human and mouse chromosomes differ due to evolutionary rearrangements.
Synteny: Conserved blocks of genetic loci across different species.
Viable offspring are possible due to compatible genetic material, but fertility depends on chromosome pairing during meiosis, which may be impaired due to structural differences.
a. Humans vs. great apes: Fewer chromosomal rearrangements; notable example is the fusion of two ancestral ape chromosomes to form human chromosome 2.
b. Humans vs. mice: Significant rearrangements, including translocations, inversions, and duplications.
A chromosomal rearrangement where two acrocentric chromosomes fuse at their centromeres, forming a single chromosome.
Mitotically: Cells can function with altered chromosome numbers.
Meiotically: Chromosomal misalignment during tetrad formation can lead to nonviable gametes or aneuploidy.